Fonar PE Ratio 2006-2020 | FONR

Current and historical p/e ratio for Fonar (FONR) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Fonar PE ratio as of August 07, 2020 is 14.75.
Fonar PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-08-07 25.81 14.75
2020-03-31 14.62 $1.75 8.35
2019-12-31 19.69 $2.13 9.24
2019-09-30 20.67 $2.20 9.40
2019-06-30 21.51 $2.21 9.73
2019-03-31 20.47 $2.99 6.85
2018-12-31 20.24 $2.94 6.88
2018-09-30 24.90 $3.04 8.19
2018-06-30 26.55 $3.10 8.56
2018-03-31 29.80 $2.53 11.78
2017-12-31 24.35 $2.90 8.40
2017-09-30 30.50 $2.92 10.45
2017-06-30 27.75 $2.92 9.50
2017-03-31 17.55 $3.01 5.83
2016-12-31 19.15 $2.58 7.42
2016-09-30 20.54 $2.48 8.28
2016-06-30 20.36 $2.37 8.59
2016-03-31 15.38 $2.27 6.78
2015-12-31 17.26 $2.13 8.10
2015-09-30 13.41 $2.00 6.71
2015-06-30 10.58 $1.95 5.42
2015-03-31 13.04 $1.71 7.62
2014-12-31 10.40 $1.66 6.27
2014-09-30 11.01 $1.59 6.92
2014-06-30 12.20 $1.58 7.72
2014-03-31 17.58 $1.70 10.34
2013-12-31 21.21 $1.61 13.17
2013-09-30 5.77 $1.49 3.87
2013-06-30 6.56 $1.34 4.90
2013-03-31 6.92 $0.82 8.44
2012-12-31 4.33 $0.85 5.09
2012-09-30 3.75 $0.88 4.26
2012-06-30 4.10 $0.90 4.56
2012-03-31 2.68 $0.72 3.72
2011-12-31 1.70 $0.72 2.37
2011-09-30 1.96 $0.72 2.72
2011-06-30 1.96 $0.55 3.56
2011-03-31 1.68 $0.52 3.23
2010-12-31 1.30 $0.32 4.06
2010-09-30 1.39 $-0.18 0.00
2010-06-30 1.47 $-0.60 0.00
2010-03-31 1.91 $-0.62 0.00
2009-12-31 1.57 $-0.62 0.00
2009-09-30 2.14 $-0.36 0.00
2009-06-30 1.90 $-0.01 0.00
2009-03-31 0.84 0 0.00
2008-12-31 0.83 0 0.00
2008-09-30 1.18 0 0.00
2008-06-30 2.25 0 0.00
2008-03-31 3.81 0 0.00
2007-12-31 5.20 0 0.00
2007-09-30 6.71 0 0.00
2007-06-30 4.97 0 0.00
2007-03-31 6.50 0 0.00
2006-12-31 7.00 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.166B $0.087B
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $179.231B 33.63
Medtronic (MDT) Ireland $134.197B 21.80
Stryker (SYK) United States $71.795B 27.84
Boston Scientific (BSX) United States $55.753B 32.21
Lonza Group Ag (LZAGY) Switzerland $46.856B 0.00
Baxter (BAX) United States $40.868B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.859B 23.95
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.171B 0.00
ResMed (RMD) United States $25.062B 36.40
Sunny Optical Technology (SNPTF) China $20.566B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $18.308B 0.00
Bio-Rad Laboratories (BIO) United States $15.555B 70.35
Insulet (PODD) United States $13.735B 604.81
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
Quidel (QDEL) United States $11.442B 60.61
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $6.885B 11.81
Hill-Rom Holdings (HRC) United States $6.336B 15.72
Canopy Growth (CGC) Canada $6.168B 0.00
Neogen (NEOG) United States $4.337B 72.47
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.204B 0.00
Haemonetics (HAE) United States $4.045B 26.95
Envista Holdings (NVST) United States $3.725B 25.40
ICU Medical (ICUI) United States $3.702B 27.01
Abcam (ABCZY) $3.462B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.396B 0.00
Agios Pharmaceuticals (AGIO) United States $2.988B 0.00
NuVasive (NUVA) United States $2.753B 38.36
National Vision Holdings (EYE) United States $2.678B 416.25
TG Therapeutics (TGTX) United States $2.314B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.945B 0.00
AtriCure (ATRC) United States $1.911B 0.00
MacroGenics (MGNX) United States $1.484B 0.00
NanoString Technologies (NSTG) United States $1.330B 0.00
Aphria (APHA) Canada $1.287B 0.00
Aurora Cannabis (ACB) Canada $1.186B 0.00
Cerus (CERS) United States $1.173B 0.00
Cardiovascular Systems (CSII) United States $1.097B 0.00
InMode (INMD) Israel $1.016B 25.62
OraSure Technologies (OSUR) United States $1.005B 0.00
Quanterix (QTRX) United States $0.942B 0.00
PetIQ (PETQ) United States $0.895B 25.85
Lantheus Holdings (LNTH) United States $0.888B 12.31
Meridian Bioscience (VIVO) United States $0.828B 19.13
Phibro Animal Health (PAHC) United States $0.825B 16.45
Owens & Minor (OMI) United States $0.813B 18.21
Vapotherm (VAPO) United States $0.781B 0.00
Omeros (OMER) United States $0.770B 0.00
BioLife Solutions (BLFS) United States $0.671B 350.33
Surmodics (SRDX) United States $0.650B 71.25
Eagle Pharmaceuticals (EGRX) United States $0.643B 46.08
VAREX IMAGING (VREX) United States $0.640B 15.90
LeMaitre Vascular (LMAT) United States $0.600B 36.62
Zynex (ZYXI) United States $0.591B 51.64
Cytosorbents (CTSO) United States $0.412B 0.00
Viemed Healthcare (VMD) United States $0.393B 14.04
Neptune Wellness Solutions (NEPT) Canada $0.325B 0.00
HEXO (HEXO) $0.319B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.22
Organigram Holdings (OGI) Canada $0.223B 0.00
Chimerix (CMRX) United States $0.211B 0.00
Female Health (VERU) United States $0.208B 0.00
Exagen (XGN) United States $0.179B 0.00
Bovie Medical (APYX) United States $0.171B 0.00
Surface Oncology (SURF) United States $0.170B 0.00
Wound Management Technologies (SMTI) United States $0.153B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.123B 0.00
Evolus (EOLS) United States $0.118B 0.00
Rockwell Medical (RMTI) United States $0.115B 0.00
Chembio Diagnostics (CEMI) United States $0.111B 0.00
Capricor Therapeutics (CAPR) United States $0.093B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
Nephros (NEPH) United States $0.071B 0.00
United-Guardian (UG) United States $0.069B 15.58
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Akers Biosciences Inc (AKER) United States $0.037B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Senestech (SNES) United States $0.007B 0.00